These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24402667)

  • 21. Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia.
    Yamada S; Tokumoto M; Tsuruya K; Tatsumoto N; Noguchi H; Kitazono T; Ooboshi H
    Am J Physiol Renal Physiol; 2015 Oct; 309(8):F744-54. PubMed ID: 26180236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
    Mathew S; Davies M; Lund R; Saab G; Hruska KA
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():43-50. PubMed ID: 16884397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia.
    Savica V; Calò LA; Monardo P; Santoro D; Mallamace A; Muraca U; Bellinghieri G
    J Ren Nutr; 2009 Jan; 19(1):69-72. PubMed ID: 19121775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral phosphate binders in patients with kidney failure.
    Tonelli M; Pannu N; Manns B
    N Engl J Med; 2010 Apr; 362(14):1312-24. PubMed ID: 20375408
    [No Abstract]   [Full Text] [Related]  

  • 25. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
    Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.
    Gutiérrez OM; Wolf M
    Semin Dial; 2010; 23(4):401-6. PubMed ID: 20557490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
    Larsson T; Nisbeth U; Ljunggren O; Jüppner H; Jonsson KB
    Kidney Int; 2003 Dec; 64(6):2272-9. PubMed ID: 14633152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphate binders in hyperphosphatemia of chronic renal failure.
    Wasan SM; Godley PJ
    DICP; 1991 Sep; 25(9):942-5. PubMed ID: 1949972
    [No Abstract]   [Full Text] [Related]  

  • 29. Hyperphosphatemia in Dialysis Patients: Beyond Nonadherence to Diet and Binders.
    Sherman RA
    Am J Kidney Dis; 2016 Feb; 67(2):182-6. PubMed ID: 26508681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are calcium-based phosphate binders ever preferable in dialysis patients?
    Jain N; Reilly RF
    Semin Dial; 2014; 27(3):269-72. PubMed ID: 24620781
    [No Abstract]   [Full Text] [Related]  

  • 31. Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats.
    Neven E; Dams G; Postnov A; Chen B; De Clerck N; De Broe ME; D'Haese PC; Persy V
    Nephrol Dial Transplant; 2009 Jun; 24(6):1790-9. PubMed ID: 19144999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new approach to the evaluation of hyperphosphatemia in chronic kidney disease.
    Savica V; Calò LA; Granata A; Caldarera R; Cavaleri A; Santoro D; Monardo P; Savica R; Muraca U; Bellinghieri G
    Clin Nephrol; 2007 Oct; 68(4):216-21. PubMed ID: 17969488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphate Binders and Clinical Outcomes in Patients with Stage 5D Chronic Kidney Disease.
    Zoccali C; Mallamaci F; Cannata-Andía J
    Semin Dial; 2015; 28(6):587-93. PubMed ID: 26278591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phosphate restriction in chronic renal failure - yes].
    Hahn KM
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1900. PubMed ID: 24022455
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of a high intake of calcium and phosphate in normal subjects and patients with chronic renal failure.
    Gower PE; Clarkson EM; Durrant C; Phillips ME; Jewkes RF; De Wardener HE
    Clin Sci; 1970 Dec; 39(6):16P-17P. PubMed ID: 5493931
    [No Abstract]   [Full Text] [Related]  

  • 36. Phosphate is a uremic toxin.
    Burke SK
    J Ren Nutr; 2008 Jan; 18(1):27-32. PubMed ID: 18089440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.
    Reddy V; Symes F; Sethi N; Scally AJ; Scott J; Mumtaz R; Stoves J
    J Ren Nutr; 2009 Jul; 19(4):314-20. PubMed ID: 19539185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phosphate sensing and intestine].
    Tatsumi S; Nomura K; Miyagawa A; Kido S; Segawa H
    Clin Calcium; 2012 Oct; 22(10):1537-41. PubMed ID: 23023634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenesis and clinical condition of hyperphosphatemic diseases].
    Hamano N; Fukagawa M
    Clin Calcium; 2016 Feb; 26(2):207-13. PubMed ID: 26813500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on phosphate binders: The old and the new.
    Cashin J; Battistella M
    CANNT J; 2016; 26(1):17-21; quiz 22-3. PubMed ID: 27215057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.